aod9604 clinical trials safety side effects AOD 9604 – The Fat-Burning Peptide: Benefits, Mechanism & AOD-9604 vs MOTS-c vs Tesamorelin

First-line obesity treatments include lifestyle intervention (e.g., low-calorie diets) and behavioral modification therapies 4,5 since approved obesity medications have limited efficacy and commonly have side effects 6

They usually start with high doses and then lower them for maintenance

By reducing NNMT catalytic activity, the compound allows researchers to evaluate how limiting nicotinamide methylation influences: In vitro and in vivo experimental models (non-clinical, non-human) have demonstrated that NNMT suppression leads to measurable changes in cellular energy markers and adipocyte behavior

, , ,

It depends on your goals

Healthcare providers are there to help, not judge